Alpha 2.0
Login Register
» Authors » Simona Piergallini

Simona Piergallini

Explore the profile of Simona Piergallini including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 41
Followers 0
Related Specialties
Gastroenterology
Pharmacology
General Medicine
Top 10 Co-Authors
Antonio Tursi
Ladislava Sebkova
Roberto Lorenzetti
Giammarco Mocci
Costantino Zampaletta
Roberto Faggiani
Marcello Picchio
Giuseppe Pranzo
Walter Elisei
Leonardo Allegretta
Published In
Pancreatology
Endoscopy
Eur J Gastroenterol Hepatol
World J Clin Cases
Eur J Intern Med
Affiliations
Soon will be listed here.
Recent Articles
1.
Use of tofacitinib as first or second-line therapy is associated with better outcomes in patients with ulcerative colitis: data from a real-world study
Tursi A, Mocci G, Cingolani L, Savarino E, Pica R, Cocco A, et al.
Expert Opin Pharmacother . 2023 Jun; 24(14):1649-1656. PMID: 37358928
Background: Data regarding the real-world (RW) use of tofacitinib (TOF) in patients with ulcerative colitis (UC) are limited. We aimed to investigate TOF's RW efficacy and safety in Italian UC...
2.
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn's disease: results from an Italian multicenter study
Mocci G, Tursi A, Maconi G, Cataletti G, Mantia B, Serio M, et al.
Expert Opin Biol Ther . 2023 Feb; 23(3):293-304. PMID: 36843568
Background: Vedolizumab (VDZ) can be used to treat refractory ulcerative colitis (UC) and Crohn's disease (CD). We assessed whether there are differences in treating UC vs CD with VDZ. Research...
3.
Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatients
Tursi A, Mocci G, Lorenzetti R, Allegretta L, Brandimarte G, Cassieri C, et al.
Eur J Gastroenterol Hepatol . 2021 Mar; 33(5):670-679. PMID: 33741797
Background: Infliximab and adalimumab are widely used for the treatment of Crohn's disease and ulcerative colitis. Aim: To compare the long-term efficacy and safety of infliximab and adalimumab in a...
4.
Infliximab biosimilar CT-P13 is effective and safe in treating inflammatory bowel diseases: a real-life multicenter, observational study in Italian primary inflammatory bowel disease centers
Tursi A, Mocci G, Faggiani R, Allegretta L, Della Valle N, Forti G, et al.
Ann Gastroenterol . 2019 Jul; 32(4):392-399. PMID: 31263362
Background: The purpose of this study was to assess the efficacy and safety of biosimilar infliximab (IFX) CT-P13 in treating outpatients with inflammatory bowel disease (IBD) in Italian primary gastroenterology...
5.
Vedolizumab is effective and safe in real-life treatment of inflammatory bowel diseases outpatients: A multicenter, observational study in primary inflammatory bowel disease centers
Tursi A, Mocci G, Faggiani R, Allegretta L, Della Valle N, De Medici A, et al.
Eur J Intern Med . 2019 Jun; 66:85-91. PMID: 31208827
Background: Italian data currently available in managing ulcerative colitis (UC) and Crohn's disease (CD) patients with vedolizumab (VDZ) are coming just from secondary and tertiary centers. The present study aimed...
6.
Successful closure of anastomotic dehiscence after colon-rectal cancer resection using the Apollo overstitch suturing system
Belfiori V, Antonini F, DeMinicis S, Marraccini B, Piergallini S, Siquini W, et al.
Endoscopy . 2017 Jun; 49(8):823-824. PMID: 28614887
No abstract available.
7.
Endoscopic Ultrasonography May Select Subjects Having Asymptomatic Chronic Pancreatic Hyperenzymemia Who Require a Stricter Follow-up
Antonini F, Belfiori V, Pagano N, Buscarini E, De Minicis S, Lo Cascio M, et al.
Pancreas . 2017 Feb; 46(4):524-527. PMID: 28196017
Objectives: We have previously shown that at least 50% of patients with asymptomatic chronic pancreatic hyperenzymemia (ACPH) may develop morphological pancreatic alterations. Endoscopic ultrasonography (EUS) may detect small lesions, and...
8.
Small bowel diverticulitis with severe anemia and abdominal pain
De Minicis S, Antonini F, Belfiori V, Lo Cascio M, Marraccini B, Piergallini S, et al.
World J Clin Cases . 2015 May; 3(5):462-5. PMID: 25984521
The current case report is related to a male patient with diabetes, obesity [body mass index (BMI) 33], hypertension and recurrence of anemia associated to melena and deep asthenia. M.P.,...
9.
Annular pancreas: unusual EUS finding in an adult patient with asymptomatic pancreatic hyperenzymemia
Antonini F, Piergallini S, Macarri G
Pancreatology . 2013 Jul; 13(3):310-1. PMID: 23858562
No abstract available.